Bliss GVS Pharma dividend 2025

BLISSGVS

157.59

5.57 (3.66%)
Last updated on 9 Oct, 2025 | 15:58 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bliss GVS Pharma Dividend Details

Record Date

24-Jul-2025

Ex Date

24-Jul-2025

Dividend Type

Equity Share

Dividend Per Share

50.00

Bliss GVS Pharma Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
24-Jul-20250.50Equity Share24-Jul-2025

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
LTIMindtree Ltd.001-Oct-202524-Oct-202524-Oct-2025
Indian Railway Finance Corporation Ltd.007-Oct-202524-Oct-202524-Oct-2025
ICICI Lombard General Insurance Company Ltd.025-Sep-202523-Oct-202523-Oct-2025
Rama Phosphates Ltd.006-Oct-202521-Oct-202520-Oct-2025
Anand Rathi Wealth Ltd.006-Oct-202517-Oct-202517-Oct-2025
Tata Consultancy Services Ltd.022-Sep-202515-Oct-202515-Oct-2025
Rashtriya Chemicals and Fertilizers Ltd.0.13227-May-202510-Oct-202510-Oct-2025
Hexaware Technologies Ltd.5.7501-Oct-202510-Oct-202510-Oct-2025

Bliss GVS Pharma Dividend FAQs

The latest dividend declared by Bliss GVS Pharma is of 0.5 per share for the financial year as announced on 24-Jul-2025.

Registered shareholders who own Bliss GVS Pharma’s shares on or before the record date of 24-Jul-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 24-Jul-2025.

You can expect to receive Bliss GVS Pharma’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 24-Jul-2025. The record date is when Bliss GVS Pharma identifies eligible shareholders for the dividend payment.

The annual dividend paid by Bliss GVS Pharma varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Bliss GVS Pharma's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.